M13-765 Extension Study for M10-855

• Research type

  Research Study

• Full title

  Long-Term Safety and Efficacy of ABT-126 in Subjects with Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855

• IRAS ID

  127169

• Contact name

  Sukhwinder Shergill

• Contact email

  sukhi.shergill@kcl.ac.uk

• Sponsor organisation

  AbbVie Deutschland, GmBH & Co. KG

• Eudract number

  2012-005661-13

• Clinicaltrials.gov Identifier

  NCT01834638

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  13/SC/0386

• Date of REC Opinion

  25 Sep 2013

• REC opinion

  Further Information Favourable Opinion